Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription


1 Antiviral Res
14 BMJ
1 J Clin Microbiol
2 J Exp Med
5 J Infect
4 J Infect Dis
3 J Virol
15 Lancet
9 Lancet Infect Dis
3 Lancet Oncol
2 Lancet Planet Health
2 Lancet Public Health
8 Lancet Respir Med
5 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 Pediatrics
5 PLoS One
4 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antiviral Res

  1. SUZUKI S, Shichinohe S, Itoh Y, Nakayama M, et al
    Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza A virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
    Antiviral Res. 2020 Apr 6:104790. doi: 10.1016/j.antiviral.2020.104790.
    PubMed         Abstract available


  2. AHMAD A, Mueller C, Tsamakis K
    Covid-19 pandemic: a public and global mental health opportunity for social transformation?
    BMJ. 2020;369:m1383.

  3. GREENBERG N, Docherty M, Gnanapragasam S, Wessely S, et al
    Managing mental health challenges faced by healthcare workers during covid-19 pandemic.
    BMJ. 2020;368:m1211.

  4. HERO I
    Prevent loss of life by providing all NHS staff with WHO standard personal protective equipment.
    BMJ. 2020;368:m1275.

  5. POLLOCK AM, Roderick P, Cheng KK, Pankhania B, et al
    Covid-19: why is the UK government ignoring WHO's advice?
    BMJ. 2020;368:m1284.

  6. CHUNG RY, Dong D, Li MM
    Socioeconomic gradient in health and the covid-19 outbreak.
    BMJ. 2020;369:m1329.

    Money injection for public services.
    BMJ. 2020;369:m1296.

  8. DONG Y, Wang L, Burgner DP, Miller JE, et al
    Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
    BMJ. 2020;369:m1043.
    PubMed         Abstract available

  9. ARONSON JK, Ferner RE
    Drugs and the renin-angiotensin system in covid-19.
    BMJ. 2020;369:m1313.

    Covid-19: Contact tracing requires ending the hostile environment.
    BMJ. 2020;368:m1320.

  11. KICKBUSCH I, Leung GM, Bhutta ZA, Matsoso MP, et al
    Covid-19: how a virus is turning the world upside down.
    BMJ. 2020;369:m1336.

  12. WYNANTS L, Van Calster B, Bonten MMJ, Collins GS, et al
    Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal.
    BMJ. 2020;369:m1328.
    PubMed         Abstract available

  13. CHEN T, Wu D, Chen H, Yan W, et al
    Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
    BMJ. 2020;368:m1091.
    PubMed         Abstract available

  14. HARGREAVES S, Kumar BN, McKee M, Jones L, et al
    Europe's migrant containment policies threaten the response to covid-19.
    BMJ. 2020;368:m1213.

  15. CALVO RA, Deterding S, Ryan RM
    Health surveillance during covid-19 pandemic.
    BMJ. 2020;369:m1373.

    J Clin Microbiol

  16. YANG G, Hodges EN, Winter J, Zanders N, et al
    Development of an RNA strand-specific hybridization assay to differentiate replicating versus non-replicating influenza A virus.
    J Clin Microbiol. 2020 Apr 3. pii: JCM.00252-20. doi: 10.1128/JCM.00252.
    PubMed         Abstract available

    J Exp Med

  17. NATHAN CF, Nussenzweig MC, Pulvirenti T
    We are here for you and ready to hear from you.
    J Exp Med. 2020;217.

  18. WEISS SR
    Forty years with coronaviruses.
    J Exp Med. 2020;217.
    PubMed         Abstract available

    J Infect

  19. LI R, Qiao S, Zhang G
    Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV.
    J Infect. 2020 Feb 21. pii: S0163-4453(20)30090.

  20. XU YH, Dong JH, An WM, Lv XY, et al
    Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2.
    J Infect. 2020 Feb 25. pii: S0163-4453(20)30100.
    PubMed         Abstract available

  21. YANG W, Cao Q, Qin L, Wang X, et al
    Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China.
    J Infect. 2020 Feb 26. pii: S0163-4453(20)30099.
    PubMed         Abstract available

  22. TIAN S, Hu N, Lou J, Chen K, et al
    Characteristics of COVID-19 infection in Beijing.
    J Infect. 2020 Feb 27. pii: S0163-4453(20)30101.
    PubMed         Abstract available

  23. HAN Q, Lin Q, Jin S, You L, et al
    Recent insights into 2019-nCoV: a brief but comprehensive review.
    J Infect. 2020 Feb 25. pii: S0163-4453(20)30087.
    PubMed         Abstract available

    J Infect Dis

  24. MOHN KG, Brokstad KA, Islam S, Oftung F, et al
    Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    J Infect Dis. 2020;221:1528-1537.
    PubMed         Abstract available

  25. RYU S, Ali ST, Cowling BJ, Lau EHY, et al
    Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
    J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
    PubMed         Abstract available

  26. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    PubMed         Abstract available

  27. SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
    A high fat diet increases influenza A virus-associated cardiovascular damage.
    J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  28. OKUYA K, Yoshida R, Manzoor R, Saito S, et al
    A potential role of non-neutralizing IgA antibodies in cross-protective immunity against influenza A viruses of multiple hemagglutinin subtypes.
    J Virol. 2020 Apr 8. pii: JVI.00408-20. doi: 10.1128/JVI.00408.
    PubMed         Abstract available

  29. PEACOCK TP, Swann OC, Salvesen HA, Staller E, et al
    Swine ANP32A supports avian influenza virus polymerase.
    J Virol. 2020 Apr 8. pii: JVI.00132-20. doi: 10.1128/JVI.00132.
    PubMed         Abstract available

  30. SHIBUYA M, Aoshi T, Kuroda E, Yoshioka Y, et al
    Murine cross-reactive non-neutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice.
    J Virol. 2020 Apr 8. pii: JVI.00323-20. doi: 10.1128/JVI.00323.
    PubMed         Abstract available


  31. SAKAMOTO H, Ishikane M, Ueda P
    Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan.
    JAMA. 2020 Apr 10. pii: 2764657. doi: 10.1001/jama.2020.6173.


  32. MCCLOSKEY B, Zumla A, Ippolito G, Blumberg L, et al
    Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma.
    Lancet. 2020 Mar 20. pii: S0140-6736(20)30681.

  33. FISHER D, Wilder-Smith A
    The global community needs to swiftly ramp up the response to contain COVID-19.
    Lancet. 2020 Mar 19. pii: S0140-6736(20)30679.

    Will COVID-19 generate global preparedness?
    Lancet. 2020 Mar 18. pii: S0140-6736(20)30559.

    Developing antibody tests for SARS-CoV-2.
    Lancet. 2020;395:1101-1102.

  36. WEISS P, Murdoch DR
    Clinical course and mortality risk of severe COVID-19.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30633.

  37. WANG J, Xu C, Wong YK, He Y, et al
    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30561.

  38. GHINAI I, McPherson TD, Hunter JC, Kirking HL, et al
    First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.
    Lancet. 2020 Mar 13. pii: S0140-6736(20)30607.
    PubMed         Abstract available

    COVID-19: learning from experience.
    Lancet. 2020;395:1011.

  40. RITCHIE AI, Singanayagam A
    Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
    Lancet. 2020;395:1111.

  41. SAGLIETTO A, D'Ascenzo F, Zoccai GB, De Ferrari GM, et al
    COVID-19 in Europe: the Italian lesson.
    Lancet. 2020;395:1110-1111.

  42. CHOWELL G, Mizumoto K
    The COVID-19 pandemic in the USA: what might we expect?
    Lancet. 2020;395:1093-1094.

    COVID-19 will not leave behind refugees and migrants.
    Lancet. 2020;395:1090.

  44. BROWN A, Horton R
    A planetary health perspective on COVID-19: a call for papers.
    Lancet. 2020;395:1099.

    Redefining vulnerability in the era of COVID-19.
    Lancet. 2020;395:1089.

  46. ELESSI K, Albarqouni L, Glasziou P, Chalmers I, et al
    Training in critical appraisal skills: Authors' reply.
    Lancet. 2020;395:e60.

    Lancet Infect Dis

  47. CHEN L, Xiong J, Bao L, Shi Y, et al
    Convalescent plasma as a potential therapy for COVID-19.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30141.

  48. ZHOU C, Gao C, Xie Y, Xu M, et al
    COVID-19 with spontaneous pneumomediastinum.
    Lancet Infect Dis. 2020 Mar 9. pii: S1473-3099(20)30156.

  49. PAN X, Chen D, Xia Y, Wu X, et al
    Asymptomatic cases in a family cluster with SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30114.

  50. SHI H, Han X, Jiang N, Cao Y, et al
    Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30086.
    PubMed         Abstract available

  51. DEVI S
    US public health budget cuts in the face of COVID-19.
    Lancet Infect Dis. 2020;20:415.

    COVID-19, a pandemic or not?
    Lancet Infect Dis. 2020 Mar 13. pii: S1473-3099(20)30180.

  53. VAN CUONG L, Giang HTN, Linh LK, Shah J, et al
    The first Vietnamese case of COVID-19 acquired from China.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30111.

  54. STEBBING J, Phelan A, Griffin I, Tucker C, et al
    COVID-19: combining antiviral and anti-inflammatory treatments.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30132.

  55. PAN Y, Zhang D, Yang P, Poon LLM, et al
    Viral load of SARS-CoV-2 in clinical samples.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30113.

    Lancet Oncol

    COVID-19: global consequences for oncology.
    Lancet Oncol. 2020;21:467.

  57. XIA Y, Jin R, Zhao J, Li W, et al
    Risk of COVID-19 for cancer patients.
    Lancet Oncol. 2020 Mar 3. pii: S1470-2045(20)30150.

  58. WANG H, Zhang L
    Risk of COVID-19 for patients with cancer.
    Lancet Oncol. 2020 Mar 3. pii: S1470-2045(20)30149.

    Lancet Planet Health

  59. KOCK RA, Karesh WB, Veas F, Velavan TP, et al
    2019-nCoV in context: lessons learned?
    Lancet Planet Health. 2020 Feb 6. pii: S2542-5196(20)30035.

  60. JI JS
    Origins of MERS-CoV, and lessons for 2019-nCoV.
    Lancet Planet Health. 2020 Jan 30. pii: S2542-5196(20)30032.

    Lancet Public Health

  61. KINNER SA, Young JT, Snow K, Southalan L, et al
    Prisons and custodial settings are part of a comprehensive response to COVID-19.
    Lancet Public Health. 2020 Mar 17. pii: S2468-2667(20)30058.

  62. TSAI J, Wilson M
    COVID-19: a potential public health problem for homeless populations.
    Lancet Public Health. 2020 Mar 11. pii: S2468-2667(20)30053.

    Lancet Respir Med

  63. LI L, Xv Q, Yan J
    COVID-19: the need for continuous medical education and training.
    Lancet Respir Med. 2020 Mar 16. pii: S2213-2600(20)30125.

    COVID-19: delay, mitigate, and communicate.
    Lancet Respir Med. 2020 Mar 16. pii: S2213-2600(20)30128.

  65. HENRY BM
    COVID-19, ECMO, and lymphopenia: a word of caution.
    Lancet Respir Med. 2020 Mar 13. pii: S2213-2600(20)30119.

  66. CAI H
    Sex difference and smoking predisposition in patients with COVID-19.
    Lancet Respir Med. 2020 Mar 11. pii: S2213-2600(20)30117.

  67. AYEBARE RR, Flick R, Okware S, Bodo B, et al
    Adoption of COVID-19 triage strategies for low-income settings.
    Lancet Respir Med. 2020 Mar 11. pii: S2213-2600(20)30114.

  68. FANG L, Karakiulakis G, Roth M
    Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
    Lancet Respir Med. 2020 Mar 11. pii: S2213-2600(20)30116.

    Respiratory support for patients with COVID-19 infection.
    Lancet Respir Med. 2020 Mar 5. pii: S2213-2600(20)30110.

  70. CHEUNG JC, Ho LT, Cheng JV, Cham EYK, et al
    Staff safety during emergency airway management for COVID-19 in Hong Kong.
    Lancet Respir Med. 2020 Feb 24. pii: S2213-2600(20)30084.

    MMWR Morb Mortal Wkly Rep

  71. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:382-386.
    PubMed         Abstract available

  72. KIMBALL A, Hatfield KM, Arons M, James A, et al
    Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:377-381.
    PubMed         Abstract available

  73. PEDERSEN R, Barton V, Tripp J, Blanton L, et al
    Notes from the Field: Seasonal Human Influenza A(H3N2) and Influenza A(H1N1)pdm09 Reassortant Infection - Idaho, 2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:427-428.

  74. ZWALD ML, Lin W, Sondermeyer Cooksey GL, Weiss C, et al
    Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:419-421.
    PubMed         Abstract available

  75. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:422-426.
    PubMed         Abstract available

    N Engl J Med

  76. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Lessons from Covid-19 Hotspots.
    N Engl J Med. 2020;382:e35.

  77. LIU W, Zhang Q, Chen J, Xiang R, et al
    Detection of Covid-19 in Children in Early January 2020 in Wuhan, China.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMc2003717.

  78. MORENS DM, Daszak P, Taubenberger JK
    Escaping Pandora's Box - Another Novel Coronavirus.
    N Engl J Med. 2020;382:1293-1295.


  79. ALCAMO AM, Wolf MS, Alessi LJ, Chong HJ, et al
    Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis.
    Pediatrics. 2019 Dec 11. pii: peds.2019-1632. doi: 10.1542/peds.2019-1632.
    PubMed         Abstract available

    PLoS One

  80. PETROPOULOS F, Makridakis S
    Forecasting the novel coronavirus COVID-19.
    PLoS One. 2020;15:e0231236.
    PubMed         Abstract available

  81. JIAO P, Fan W, Cao Y, Zhang H, et al
    Robust induction of interferon and interferon-stimulated gene expression by influenza B/Yamagata lineage virus infection of A549 cells.
    PLoS One. 2020;15:e0231039.
    PubMed         Abstract available

  82. TUCKERMAN J, Crawford NW, Marshall HS
    Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination.
    PLoS One. 2020;15:e0230425.
    PubMed         Abstract available

  83. ANASTASSOPOULOU C, Russo L, Tsakris A, Siettos C, et al
    Data-based analysis, modelling and forecasting of the COVID-19 outbreak.
    PLoS One. 2020;15:e0230405.
    PubMed         Abstract available

  84. PIEDRA FA, Qiu X, Teng MN, Avadhanula V, et al
    Non-gradient and genotype-dependent patterns of RSV gene expression.
    PLoS One. 2020;15:e0227558.
    PubMed         Abstract available


  85. WANG SH, Chen J, Smith D, Cao Z, et al
    A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.
    Vaccine. 2020;38:3537-3544.
    PubMed         Abstract available

  86. SURAGH TA, Hibbs B, Marquez P, McNeil MM, et al
    Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30418.
    PubMed         Abstract available

  87. SUGISHITA Y, Nakayama T, Sugawara T, Ohkusa Y, et al
    Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30378.
    PubMed         Abstract available

  88. NGUYEN VH, Vizzotti C, Uruena A, Giglio N, et al
    Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.
    Vaccine. 2020;38:3682-3689.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.